Silk Road Medical (NASDAQ:SILK) ticked lower by 0.4% after a note that the company's planned sale to Boston Scientific (NYSE:BSX) may see an in-depth U.S. antitrust review. The deal could see a second ...
Original Image Link
Source:www.msn.com
Original Image Link
Source:www.msn.com
Posted: 2024-08-08 11:11:24